American Journal of Clinical Oncology
-
Publication Venue For
-
Competing Mortality in Patients With Neuroendocrine Tumors..
42:668-674.
2019
-
Chemoradiation Versus Chemotherapy in Uterine Carcinosarcoma: Patterns of Care and Impact on Overall Survival..
41:784-791.
2018
-
Radiation therapy in the treatment of minor salivary gland tumors..
37:492-497.
2014
-
Combined-modality therapy for rectal cancer: analysis of potential differences in disease presentation, treatment adherence, and treatment outcome according to race..
37:122-125.
2014
-
Results of the 2005 to 2008 Association of Residents in Radiation Oncology surveys of chief residents in the United States: didactics and research experience..
35:32-39.
2012
-
Weekly paclitaxel and carboplatin induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck..
35:6-12.
2012
-
The effect of dental artifacts, contrast media, and experience on interobserver contouring variations in head and neck anatomy..
30:191-198.
2007
-
Low-dose radiation for posttransplant lymphoproliferative disorder..
26:210-214.
2003
-
Phase II study of MGI-114 administered intravenously for 5 days every 28 days to patients with metastatic colorectal cancer..
26:132-134.
2003
-
Phase II study of dolastatin-10 as first-line treatment for advanced colorectal cancer..
25:451-453.
2002
-
The corporate presence at oncology meetings..
25:535-536.
2002
-
Metastatic dedifferentiated chordoma with elevated beta-hCG: a case report..
25:274-276.
2002
-
Irinotecan treatment for recurrent malignant glioma using an every-3-week regimen..
25:204-208.
2002
-
Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer..
24:107-112.
2001
-
Phase II study of intravenous CI-958 in metastatic colorectal adenocarcinoma..
23:602-604.
2000
-
Adjuvant sequential chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil (ACMF) with concurrent radiotherapy in resectable advanced breast cancer..
23:122-127.
2000
-
Tumor lysis syndrome and acute renal failure after treatment of non-small-cell lung carcinoma with combination irinotecan and cisplatin..
21:426-429.
1998
-
Phase II trial of intravenous CI-980 (NSC 370147) in patients with metastatic colorectal carcinoma. Model for prospective evaluation of neurotoxicity..
20:573-576.
1997
-
A phase II study of cisplatin, 5-fluorouracil, leucovorin, and etoposide in advanced non-small-cell lung cancer..
20:128-131.
1997
-
Neck failure in T2N0 squamous cell carcinoma of the true vocal cords: the Fox Chase experience and review of the literature..
20:154-157.
1997
-
Phase I trial of etoposide, carboplatin, and GM-CSF in extensive small-cell lung cancer: a Cancer and Leukemia Group B study (CALGB 8832)..
20:24-30.
1997
-
Phase II study of docetaxel in advanced soft tissue sarcomas..
19:574-576.
1996
-
Late onset of isolated central nervous system metastasis of liposarcoma--a case report..
19:351-355.
1996
-
Positron emission tomography in the pretreatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy: preliminary findings..
19:416-421.
1996
-
Pilot phase II trial of 13-cis-retinoic acid and interferon-alpha combination therapy for advanced pancreatic adenocarcinoma..
18:525-527.
1995
-
A phase II study of tamoxifen combined with cisplatin-interleukin 2 and alpha-interferon in metastatic melanoma..
18:421-424.
1995
-
Phase II trial of isotretinoin and recombinant interferon alfa-2a in metastatic colorectal carcinoma..
18:436-438.
1995
-
A phase II study of recombinant interferon-gamma following combination chemotherapy for patients with extensive small cell lung cancer. CALGB..
18:67-70.
1995
-
Lorazepam-enhancement of the antiemetic efficacy of dexamethasone and promethazine. A placebo-controlled study..
17:417-421.
1994
-
Nongenital granuloma inguinale in an oncology patient..
17:456-460.
1994
-
The Bird's Nest Filter. An alternative to long-term oral anticoagulation in patients with advanced malignancies..
17:115-117.
1994
-
An analysis of radiotherapy data from the CNS cancer consortium's randomized prospective trial comparing AZQ to BCNU in the treatment of patients with primary malignant brain tumors. The CNS cancer consortium..
16:277-283.
1993
-
Extramedullary plasmacytoma of the pancreas..
16:363-368.
1993
-
Phase II evaluation of iproplatin in patients with advanced gastric and pancreatic cancer..
15:524-527.
1992
-
Adjuvant postoperative radiation therapy for rectal adenocarcinoma..
15:371-375.
1992
-
Intensive etoposide and carboplatin chemotherapy for advanced non-small-cell lung cancer. A phase II trial of the Cancer and Leukemia Group B..
15:399-404.
1992
-
Fotemustine (S 10036) in the intra-arterial treatment of liver metastasis from malignant melanoma. A phase II Study..
14:400-404.
1991
-
Metastatic adenocarcinomas of unknown primary site. Prognostic variables and treatment results..
13:55-60.
1990
-
A phase II trial of streptozotocin and adriamycin in advanced APUD tumors..
11:490-495.
1988
-
Biological and clinical aspects of hyperthermia in cancer therapy..
11:368-380.
1988
-
Effects of oxygen on the metabolism of murine tumors using in vivo phosphorus-31 NMR..
10:475-482.
1987
-
Coital risk factors for cervical cancer. Sexual activity among white middle class women..
10:222-226.
1987
-
Evaluation of new anticancer agents against human pancreatic carcinomas in nude mice..
10:219-221.
1987
-
High-dose amsacrine (AMSA) therapy of relapsed and refractory adult acute nonlymphocytic leukemia. A phase II study..
7:361-363.
1984
-
Scanning with L-(13 N) glutamate: Assessment of the response to chemotherapy of a patient with embryonal rhabdomyosarcoma..
5:285-289.
1982
-
Hexamethylmelamine and prednisone in the treatment of refractory multiple myeloma..
5:21-27.
1982